Clinical trial

Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease…

NCT00272948 · European Society for Blood and Marrow Transplantation, Other · Completed

Key facts

NCT number NCT00272948
Title Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide
Official title Prospective Randomized Study of the Incidence and Outcome of Veno-Occlusive Disease (VOD) With the Prophylactic Use of Defibrotide (DF) in Pediatric Stem Cell Transplantation
Acronym VOD-DF
Lead sponsor European Society for Blood and Marrow Transplantation, Other
Collaborators Jazz Pharmaceuticals Industry Deutsche Krebshilfe e.V., Bonn (Germany)
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Hepatic Veno-Occlusive Disease
Intervention type Drug
Interventions Defibrotide
Enrollment 360
Start date Dec 1, 2005
Primary completion Jan 1, 2009
Completion Jul 1, 2009
First posted Jan 9, 2006
Last update posted Jun 9, 2011
Countries Austria, France, Germany, Ireland, Israel, Italy, Netherlands, Sweden, Switzerland, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies